Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Rank in Stocks #350
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Share Price
$48.97
Market Cap
$72.79B
Change (1 day)
1.93%
Change (1 year)
-54.09%
Country
US
Trade Boston Scientific Corporation (BSX)

Category

EPS for Boston Scientific Corporation (BSX)
EPS as of June 2026 TTM: $2.48
According to Boston Scientific Corporation latest financial reports and stock price the company's current EPS (TTM) is $2.48. At the end of 2024 the company had a EPS of $1.26 an increase over its 2023 EPS that were of $1.08.
EPS history for Boston Scientific Corporation from 2000 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $2.48 26.53%
2025 $1.96 55.56%
2024 $1.26 16.61%
2023 $1.08 140.75%
2022 $0.45 -35.19%
2021 $0.69 -952.83%
2020 $-0.08 -102.40%
2019 $3.38 179.14%
2018 $1.21 1,412.50%
2017 $0.08 -69.23%
2016 $0.26 -244.44%
2015 $-0.18 100.00%
2014 $-0.09 0.00%
2013 $-0.09 -96.89%
2012 $-2.89 -1,096.55%
2011 $0.29 -141.43%
2010 $-0.70 2.94%
2009 $-0.68 -50.00%
2008 $-1.36 312.12%
2007 $-0.33 -88.26%
2006 $-2.81 -469.74%
2005 $0.76 -40.16%
2004 $1.27 122.81%
2003 $0.57 23.91%
2002 $0.46 -807.69%
2001 $-0.07 -114.13%
2000 $0.46 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$3.11 25.40%
US
$9.73 292.34%
US
$3.59 44.76%
IE
$1.74 -29.84%
US
- -
DE